NCT04883697

Completed

Retrospective Evaluation of Risk Factors for Lower Outcomes ...

Vienna Institute for Research in Ocular Surgery Source

Compare

Other study identifiers

Sponsor study identifier

RAI

Study Type

observational

Actual enrollment (reported)

71

Locations

1 country

Sites

1

Timeline

Study Start

January 1, 2021

Actual (reported)

Primary Completion

May 1, 2021

Actual (reported)

Study Completion

May 1, 2021

Actual (reported)

Brief Summary

A retrospective review of medical charts of patients having undergone vitrectomy with ILM Peeling and ILM flap technique for macular hole repair.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 71 participants
Study completion date: May 1, 2021
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 1, 2021
Actual (reported)
First Submitted
May 1, 2021
Actual (reported)
Primary Completion
May 1, 2021
Actual (reported)
Study Completion
May 1, 2021
Actual (reported)
First Posted
May 12, 2021
Actual (reported)

Last Updated: May 12, 2021
Status Verified: May 2021
Last Update Submitted: May 6, 2021

Conditions

Macular Holes

Outcome Measures

Primary Outcomes (2)

visual acuity
best corrected distance visual acuity
change between visual acuity 2-6 months postoperative to baseline
macular hole closure
closure of the macular hole assesed with OCT
2-6 months postoperative

Interventions

vitrectomy with ILM peeling and ILM flap techniqueOther

outcomes after vitrectomy with ILM peeling and ILM flap technique for macukar hole repair are assessed

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 105 Years

Sexall

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

all patieints have undergone vitrectomy with ILM peeling and ILM flap technique in the time period form 1.1.2015 to 31.4.2020 for macular hole repair

You may qualify if:

Vitrectomy with ILM peeling and ILM flap technique in the time period form 1.1.2015 to 31.4.2020

Sponsors & Collaborators

Vienna Institute for Research in Ocular Surgery
Otherlead

Study Sites (1)

Vienna Institute for Research in Ocular Surgery

Vienna, 1140, Austria

MeSH Terms

Conditions

Retinal Perforations

Interventions

Vitrectomy

Condition Hierarchy (Ancestors)

Retinal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Ophthalmologic Surgical ProceduresSurgical Procedures, Operative

Study Officials

Oliver Findl
Vienna Institute for Research in Ocular Surgery
PRINCIPAL INVESTIGATOR

Enrollment

71 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Prim., Prof., MBA

Study Record Dates

First Submitted

May 1, 2021

First Posted

May 12, 2021

Study Start

January 1, 2021

Actual (reported)

NCT04135638

Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison

Not ApplicableUnknown

NCT06063005

Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole

Not ApplicableUnknown

NCT06359548

PEELED INTERNAL LIMITING MEMBRANE REPOSITION

Not ApplicableRecruiting

NCT05269563

Double Flap Technique for Macular Hole

Not ApplicableCompleted

NCT04116892

Comparative Analysis of Large Macular Hole Surgeries

Not ApplicableUnknown

NCT01687829

Macular Hole Surgery With and Without Internal Limiting Membrane Peeling：A Systematic Review and Meta-analysis

Unknown

Age 18 or older

You may not qualify if:

Age \<18

Contact the study team to confirm eligibility.

Primary Completion

May 1, 2021

Actual (reported)

Study Completion

May 1, 2021

Actual (reported)

Last Updated

May 12, 2021

Record last verified: 2021-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04883697
Data provider: ClinicalTrials.gov
Source updated: 2021-05-12
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:32:32 UTC

Locations

AT(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

Primary Completion

Study Completion

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations